From the Clinical Cooperative Group Hemopoietic Cell Transplantation, and the Institute of Molecular Immunology, GSF-National Research Center for Environment and Health, Department of Medicine, Klinikum Grosshadern, University of Munich, Munich, Germany; Division of Hematology and Department of Medicine, University of Washington, Seattle; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA; and ARIAD Pharmaceuticals, Cambridge, MA.
Conditional suicide genes derived from pathogens have been developed to confer drug sensitivity and enhance safety of cell therapy, but this approach is limited by immune responses to the transgene product. We examined a strategy to regulate survival of transferred cells based on induction of apoptosis through oligomerization of a modified human Fas receptor by a bivalent drug (AP1903). Three macaques (Macaca nemestrina) received autologous T cells retrovirally engineered to express a Fas suicide-construct (LV'VFas). High levels of transduced cells were present in blood following cell transfer, but LV'VFas+ cells declined rapidly after AP1903 administration. A small fraction of LV'VFas+ cells resisted elimination by AP1903, in part due to insufficient levels of transgene expression in resting T cells, because reactivation of these cells in vitro enhanced sensitivity to AP1903. An immune response to the transgene product was observed, but epitope mapping indicated the response was directed to discrete components of human LV'VFas that were variant with the corresponding macaque sequences. These data demonstrate that chemically induced dimerization can be used to regulate survival of adoptively transferred T cells in vivo.
Related Articles in Blood Online :
- Dimerize and die.
Karin C. Straathof and Helen E. Heslop Blood 2004 103: 1177-1178.[Full Text]
A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis
A novel SHP-1/Grb2–dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation
Allergen exposure–induced differences in CD34+ cell phenotype: relationship to eosinophilopoietic responses in different compartments
And a final message from antithrombin
Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells
Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy
Anti-CD40L: biology and therapy in ITP
BUBR1 deficiency results in abnormal megakaryopoiesis
Cell adhesion: a partner for many